|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 多数免疫功能正常的原发性中枢神经系统弥漫性大B细胞淋巴瘤为非生发中心亚型显示文摘 | Hattab E M Martin S E Al-Khatib S M 刘勇 | 2010 | 临床与实验病理学杂志2010，26，4： | 13 |
| 2 | 急性脊髓损伤患者治疗的临床操作指南:关于MRI基线在临床治疗决策与结果预测中作用的几点建议(英文)显示文摘The objective of this guideline is to outline the role of magnetic resonance imaging(MRI) in clinical decision making and outcome prediction in patients with traumatic spinal cord injury(SCI).Methods A systematic review of the literature was conducted to address key questions related to the use of MRI in patients with traumatic SCI.This review focused on longitudinal studies that controlled for baseline neurologic status.A multidisciplinary Guideline Development Group(GDG) used this information,their clinical expertise,and patient input to develop recommendations on the use of MRI for SCI patients.Based on GRADE(Grading of Recommendation,Assessment,Development and Evaluation),a strong recommendation is worded as ' we recommend,' whereas a weaker recommendation is indicated by 'we suggest.' Results Based on the limited available evidence and the clinical expertise of the GDG,our recommendations were:(1) 'We suggest that MRI be performed in adult patients with acute SCI prior to surgical intervention,when feasible,to facilitate improved clinical decision-making'(quality of evidence,very low) and(2) 'We suggest that MRI should be performed in adult patients in the acute period following SCI,before or after surgical intervention,to improve prediction of neurologic outcome '(quality of evidence,low).Conclusions These guidelines should be implemented into clinical practice to improve outcomes and prognostication for patients with SCI. | Fehlings MG Martin AR Tetreault LA Aarabi B Anderson P Arnold PM Brodke D Burns AS Chiba K Dettori JR Furlan JC Hawryluk G Holly LT Howley S Jeji T Kalsi-Ryan S Kotter M Kurpad S Kwon BK Marino RJ Massicotte E Merli G Middleton JW Nakashima H Nagoshi N Palmieri K Singh A Skelly AC Tsai EC Vaccaro A Wilson JR Yee A Harrop JS | 2017 | 中华神经外科疾病研究杂志2017，16，6： | 8 |
| 3 | 重症败血症患者炎性介质水平对预后的影响显示文摘目的 :探索可早期预测败血症预后的炎性介质指标。方法 :前瞻性研究 ,观察期 2 8日 ,分析重症败血症患者与死亡相关的临床和实验室指标。结果 :共连续观察 2 6例 ,死亡 14例 (5 3.8%) ,且多死于研究阶段的第1周内 (74.0 %)。死亡组患者血总胆红素水平、4项全身炎性反应综合征 (SIRS)指标的积分和循环中的细胞间黏附分子 1(s ICAM 1)水平明显高于死亡组 ,其它炎性因子包括一些细胞因子和黏附分子的水平在 2组间差异不大。结论 :败血症患者的 s ICAM | 赵擎宇 张春玲 黄子通 M A Weigand H J Bardenheuer E Martin | 2001 | 中国危重病急救医学2001，13，11： | 7 |
| 4 | Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions显示文摘During the last 15 years we have witnessed an unprecedented expansion in the drugs developed to target human epidermal growth factor receptor-2(HER-2) positive breast cancer. Trastuzumab, pertuzumab, adotrastuzumab emtansine and lapatinib are currently food and drug administration(FDA)-approved for the treatment of breast cancer patients with HER-2 overexpressed. However, given the amount of information gathered from years of uninterrupted clinical research, it is essential to have periodic updates that succinctly recapitulate what we have learnt over these last years and help us to apply that information in our daily practice. This review will pursue that objective. We will summarize the most relevant and updated informationrelated to the state of the art management of HER-2 positive breast cancer in all the clinical scenarios including the adjuvant, neoadjuvant and metastatic settings. But we will also critically appraise that literature in order to highlight some key clinical concepts that should not be overlooked. Lastly, this review will also point out some of the most promising strategies that are currently being tested and may soon become available. | Gonzalo Recondo Jr Enrique Dìaz Canton Màximo de la Vega Martin Greco Gonzalo Recondo Sr Matias E Valsecchi | 2014 | World Journal of Clinical Oncology2014，5，3： | 7 |
| 5 | Acute pancreatitis in aging animals:Loss of pancreatitis-associated protein protection?显示文摘AIM:To investigate the effect of age on severity of acute pancreatitis(AP) using biochemical markers,histology and expression of the protective pancreatitisassociated proteins(PAPs).METHODS:AP was induced via intraductal injection of 4% sodium taurocholate in young and old rats.Sera and pancreata were assayed at 24 h for the parameters listed above;we also employed a novel molecular technique to assess bacterial infiltration using polymerase chain reaction to measure bacterial genomic ribosomal RNA.RESULTS:At 24 h after induction of AP,the pancreata of older animals had less edema(mean ± SE histologic score of young vs old:3.11 ± 0.16 vs 2.50 ±-0.11,P < 0.05),decreased local inflammatory response(histologic score of stromal infiltrate:3.11 ± 0.27 vs 2.00 ± 0.17,P < 0.05) and increased bacterial infiltration(174% ± 52% increase from sham vs 377% ± 4%,P < 0.05).A decreased expression of PAP1 and PAP2 was demonstrated by Western blotting analysis and immunohistochemical staining.There were no differences in serum amylase and lipase activity,or tissue myeloperoxidase or monocyte chemotactic protein-1 levels.However,in the most-aged group,serum C-reactive protein levels were higher(young vs old:0.249 ± 0.04 mg/dL vs 2.45 ± 0.68 mg/dL,P < 0.05).CONCLUSION:In older animals,there is depressed PAP expression related to a blunted inflammatory response in AP which is associated with worsened bacterial infiltration and higher C-reactive protein level;this may explain the more aggressive clinical course. | Sophia Fu Albert Stanek Cathy M Mueller Nefertti A Brown Chongmin Huan Martin H Bluth Michael E Zenilman | 2012 | World Journal of Gastroenterology2012，18，26： | 5 |
| 6 | Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘 | Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella | 2011 | The Lancet . 2011 (9807)2011，，9807： | 2 |
| 7 | Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘 | Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella | 2011 | The Lancet2011，，9807： | 2 |
| 8 | Advances and new perspectives in the treatment of metastatic colon cancer显示文摘During the last decade we have witnessed an unprec-edented outburst of new treatment approaches for the management of metastatic colon cancer.Anti-angio-genic drugs,epidermal growth factor receptor blockers and multi-kinase inhibitors have all resulted in small but consistent improvement in clinical outcomes.However,this progress has paradoxically leaded us into new chal-lenges.In many cases the clinical development was done in parallel and the lack of head-to-head compari-son evolved into circumstances where several valid new'standards of care'are available.Even though desir-able in essence,the availability of many options as well as different possible combinations frequently leaves the busy clinician in the difficult situation of having to choose between one or the other,sometimes without solid evidence to support each decision.In addition,progress never stops and new agents are continuously tested.For these reason this review will try to summa-rize all the clinical trials that constitute the theoretical framework that support our daily practice but will also procure the reader with rational answers to common clinical dilemmas by critically appraising the current literature.Lastly,we will provide with a compilation of promising new agents that may soon become our next line of defense against this deadly disease. | Gonzalo Recondo Jr Enrique Díaz-Cantón Máximo de la Vega Martin Greco Gonzalo Recondo Sr Matias E Valsecchi | 2014 | World Journal of Gastrointestinal Oncology2014，6，7： | 2 |
| 9 | Effects of organic pollution on transplanted aquatic bryophytes 显示文摘 | MARTINE Abaigar J NUNEZ Olivera E SANCHEZ Diaz M | 1993 | J Bryol1993，17，4： | 2 |
| 10 | 钒微合金化钢的热影响区韧性显示文摘研究了结构钢单道次焊接接头,尤其是靠近融合线位置的粗晶热影响区(CGHAZ)的组织和力学性能。通常,这个区域的韧性比母材和焊缝金属的韧性要低很多,所以CGHAZ是最容易发生断裂的薄弱位置。重点关注钒微合金化钢板,并且与相同强度级别的铌微合金化钢板进行对比。为了充分利用钒的强化效果,有必要将氮含量提高至0.01%;为优化钢的性能,必须考虑钒与氮的配合。 | Fahlstrm K Hutchinson B Komenda J Lindh-Ulmgren E Martin D Beladi H 师仲然 王瑞珍 | 2015 | 钢铁钒钛2015，36，3： | 2 |
| 11 | Postpartum hemolytic uremic syndrome:a rare entity and a treatment challenge 显示文摘 | Alsina Segui E Martin Conde M Craver Hospital L Fernandez Oiraldez E | 2008 | Nefrologia2008，28，： | 1 |
| 12 | Cyclodextrins and their uses: a review显示文摘 | E M Martin Del Valle | 2004 | Process Biochemistry2004，39，： | 1 |
| 13 | Finite element studies of the deformation of the pelvic floor显示文摘 | MARTINS J A PATO M P PIRES E B | 2007 | Ann N Y Acad Sci2007，1101，： | 1 |
| 14 | Vascular events after spinal cord injury: contribution to secondary pathogenesis显示文摘 | Angelika E M Martin R W Frances D | 2000 | Phys Ther2000，80，7： | 1 |
| 15 | Immunoproliferative small intestinal disease associated with campylobacter jejuni显示文摘 | Lecuit M Abachin E Martin A | 2004 | N Engl J Med2004，350，3： | 1 |
| 16 | BisoGenet: a new tool for gene network building, visualization and analysis 显示文摘 | Martin A Ochagavia M E Rabasa L C | 2010 | BMCBioinformatics2010，11，： | 1 |
| 17 | Emergy evaluation of the performance and sustainability of three agricultural systems with different scales and management显示文摘 | Martin J F Diemont S A W Powell E Stanton M Levy-Tacher S | 2006 | Agriculture Ecosystems&Environment2006，115，14： | 1 |
| 18 | Iron deficiency limits phytoplankton growth in Antarctic waters显示文摘 | Martin J H Fitzwater S E Gordon R M | | 0，，： | 1 |
| 19 | Late onset psychogenic nonepileptic attacks 显示文摘 | Duncan R Oto M Martin E | 2006 | Neurology2006，66，11： | 1 |
| 20 | Clinical stem cell therapies for se- vere autoimmune diseases显示文摘 | Snowden J A Martin R E Watt S M | 2009 | Transfus Med2009，19，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员